Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Builds Foundation for Biomarker-Driven Cancer Therapybusinessinsider·1 day ago, 11:31 AMONCO-1.66%
Onconetix Q2 net loss widens 20.9% to $2.87 million; revenue drops 83.9% to $17,120 vs year-ago quarterPUBT·Aug 13 at 03:16 PMONCO-1.66%LH+1.03%
Onco-Innovations identifies non-tin catalyst to advance ONC010 polymer developmentPUBT·Aug 12 at 05:00 PMONCO-1.66%
Realbotix Q3 2026 earnings: Robotics sales rise as total revenue fallsTradingKey·Aug 12 at 06:44 AMONCO-1.66%
Realbotix Q3 FY26 operating loss widens to USD 1.7 million; revenue drops to USD 354,000PUBT·Aug 12 at 06:32 AMONCO-1.66%
Onconetix prices USD 30.25 million PIPE via Series F convertible preferred stock salePUBT·Jul 29 at 04:22 PMONCO-1.66%
12 Health Care Stocks Moving In Wednesday's After-Market Sessionbenzinga_article·Jul 29 at 04:06 PMCORT+0.97%TDOC-0.99%
Realbotix outlines holding-company structure with separate commercial robotics, DTC adult wellness unitsPUBT·Jul 22 at 10:25 AMONCO-1.66%
Pre-market hot trades in US stocks: Digitalocean up 15.32% in pre-market; Onconetix down 11.15% in pre-marketPrice Alert·Jul 7 at 08:07 AMDOCN-9.46%ONCO-1.66%
Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social IsolationUnusual Whales·Jul 7 at 08:02 AMONCO-1.66%
Pre-market hot trades in US stocks: Onconetix pre-market down 7.08%; MaxLinear pre-market down 7.05%Price Alert·Jul 1 at 08:12 AMONCO-1.66%MXL-14.60%
Onco-Innovations starts polymer process development, characterization program for ONC010 nanoparticle PNKP inhibitorPUBT·Jun 30 at 05:00 PMONCO-1.66%
Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF): Cancer Nanomedicine Enters a New Generationbusinessinsider·Jun 25 at 01:15 PMONCO-1.66%
